GHP Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $226K | Sell |
9,384
-1,242
| -12% | -$32.5K | 0.01% | 389 |
|
|
2026
Q1 | $298K | Sell |
10,626
-301
| -3% | -$8.01K | 0.01% | 358 |
|
|
2025
Q4 | $272K | Sell |
10,927
-2,108
| -16% | -$53.2K | 0.01% | 359 |
|
|
2025
Q3 | $332K | Buy |
13,035
+110
| +0.9% | +$2.71K | 0.01% | 338 |
|
|
2025
Q2 | $313K | Sell |
12,925
-598
| -4% | -$13.9K | 0.01% | 339 |
|
|
2025
Q1 | $343K | Buy |
13,523
+1,517
| +13% | +$39.7K | 0.02% | 329 |
|
|
2024
Q4 | $319K | Sell |
12,006
-1,691
| -12% | -$45.9K | 0.01% | 334 |
|
|
2024
Q3 | $396K | Buy |
13,697
+1,108
| +9% | +$32.3K | 0.02% | 322 |
|
|
2024
Q2 | $352K | Buy |
12,589
+620
| +5% | +$17.1K | 0.02% | 326 |
|
|
2024
Q1 | $332K | Buy |
11,969
+621
| +5% | +$17.2K | 0.02% | 333 |
|
|
2023
Q4 | $327K | Sell |
11,348
-229
| -2% | -$6.92K | 0.02% | 335 |
|
|
2023
Q3 | $372K | Sell |
11,577
-813
| -7% | -$28.8K | 0.02% | 319 |
|
|
2023
Q2 | $447K | Buy |
12,390
+56
| +0.5% | +$2.18K | 0.03% | 312 |
|
|
2023
Q1 | $503K | Sell |
12,334
-998
| -7% | -$43.1K | 0.03% | 299 |
|
|
2022
Q4 | $683K | Buy |
13,332
+307
| +2% | +$14.7K | 0.05% | 283 |
|
|
2022
Q3 | $570K | Sell |
13,025
-605
| -4% | -$29.4K | 0.04% | 284 |
|
|
2022
Q2 | $715K | Sell |
13,630
-1,080
| -7% | -$55K | 0.05% | 263 |
|
|
2022
Q1 | $762K | Sell |
14,710
-355
| -2% | -$18.4K | 0.05% | 265 |
|
|
2021
Q4 | $890K | Sell |
15,065
-254
| -2% | -$12.6K | 0.06% | 220 |
|
|
2021
Q3 | $659K | Sell |
15,319
-575
| -4% | -$25.5K | 0.05% | 223 |
|
|
2021
Q2 | $622K | Buy |
15,894
+678
| +4% | +$26.4K | 0.05% | 224 |
|
|
2021
Q1 | $551K | Sell |
15,216
-254
| -2% | -$9.02K | 0.05% | 226 |
|
|
2020
Q4 | $569K | Buy |
15,470
+454
| +3% | +$16.7K | 0.05% | 213 |
|
|
2020
Q3 | $523K | Buy |
15,016
+626
| +4% | +$21.9K | 0.06% | 214 |
|
|
2020
Q2 | $446K | Sell |
14,390
-146
| -1% | -$4.96K | 0.06% | 225 |
|
|
2020
Q1 | $450K | Buy |
14,536
+131
| +0.9% | +$4.46K | 0.07% | 224 |
|
|
2019
Q4 | $535K | Buy |
14,405
+350
| +2% | +$12.5K | 0.06% | 227 |
|
|
2019
Q3 | $479K | Buy |
14,055
+19
| +0.1% | +$691 | 0.06% | 234 |
|
|
2019
Q2 | $577K | Sell |
14,036
-84
| -0.6% | -$3.34K | 0.07% | 226 |
|
|
2019
Q1 | $569K | Buy |
14,120
+41
| +0.3% | +$1.64K | 0.07% | 218 |
|
|
2018
Q4 | $583K | Buy |
14,079
+84
| +0.6% | +$3.49K | 0.09% | 208 |
|
|
2018
Q3 | $585K | Sell |
13,995
-552
| -4% | -$21.3K | 0.08% | 216 |
|
|
2018
Q2 | $501K | Buy |
14,547
+575
| +4% | +$19.6K | 0.07% | 227 |
|
|
2018
Q1 | $470K | Buy |
13,972
+10
| +0.1% | +$344 | 0.07% | 231 |
|
|
2017
Q4 | $480K | Sell |
13,962
-244
| -2% | -$8.32K | 0.07% | 229 |
|
|
2017
Q3 | $481K | Buy |
14,206
+584
| +4% | +$18.8K | 0.07% | 231 |
|
|
2017
Q2 | $434K | Buy |
13,622
+10
| +0.1% | +$315 | 0.07% | 238 |
|
|
2017
Q1 | $442K | Buy |
13,612
+1,573
| +13% | +$49.6K | 0.08% | 231 |
|
|
2016
Q4 | $371K | Buy |
12,039
+2,096
| +21% | +$64K | 0.07% | 241 |
|
|
2016
Q3 | $320K | Buy |
9,943
+865
| +10% | +$28.9K | 0.07% | 241 |
|
|
2016
Q2 | $303K | Buy |
9,078
+846
| +10% | +$27K | 0.07% | 245 |
|
|
2016
Q1 | $232K | Buy |
8,232
+705
| +9% | +$20.1K | 0.05% | 258 |
|
|
2015
Q4 | $231K | Sell |
7,527
-109
| -1% | -$3.43K | 0.06% | 260 |
|
|
2015
Q3 | $228K | Buy |
7,636
+145
| +2% | +$4.65K | 0.06% | 254 |
|
|
2015
Q2 | $244K | Buy |
+7,491
| New | +$244K | 0.06% | 245 |
|
|
2014
Q1 | – | Sell |
-7,137
| Closed | -$207K | – | 269 |
|
|
2013
Q4 | $207K | Sell |
7,137
-2,307
| -24% | -$67.1K | 0.07% | 244 |
|
|
2013
Q3 | $257K | Buy |
9,444
+257
| +3% | +$6.99K | 0.09% | 219 |
|
|
2013
Q2 | $244K | Buy |
+9,187
| New | +$254K | 0.1% | 215 |
|
Other funds holding PFE
GHP Investment Advisors's PFE Position: Q2 2026 in Review
GHP Investment Advisors reduced its Pfizer (PFE) stake by 12% in Q2 2026, selling an estimated $32.5K and leaving 9,384 shares worth $226K. The position accounts for 0.01% of the portfolio, ranked #389.
GHP Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $890K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- GHP Investment Advisors held 9,384 shares of Pfizer worth $226K as of Q2 2026.
- GHP Investment Advisors sold 1,242 Pfizer shares in Q2 2026, an estimated $32.5K.
- Pfizer made up 0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #389 holding.
- GHP Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
- GHP Investment Advisors's Pfizer position peaked at $890K in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.